Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5138 participants.

Also called NCT06853535

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 5,138 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06853535
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06853535. Randomized; no masking; primary purpose prevention. Start 2025-05-23 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
Acronym
PATH STROKE C
Condition
Acute Ischemic Stroke
Condition
Clopidogrel Resistance
Intervention (Drug)
The ticagrelor
Intervention (Drug)
The Clopidogrel
Lead sponsor
Sichuan Provincial People's Hospital (class: other)
Collaborator
Fudan University (class: other)
Collaborator
Chengdu Medical College (class: other)

Record details

Record id
cardio:ct-nct06853535
Content hash
74616b1265d7be4afa0ff7851297eeb52001bd97d2832c808fe60a33c3cba862